Executive with over 25 years of leadership experience in large pharmaceuticals, biotech (established and start-up), and medical device (software and diagnostics). Extensive experience in all aspects of commercialization in the healthcare industry. In particular, strong background in oncology, ...more

Executive with over 25 years of leadership experience in large pharmaceuticals, biotech (established and start-up), and medical device (software and diagnostics). Extensive experience in all aspects of commercialization in the healthcare industry. In particular, strong background in oncology, hematology, vaccines, and diabetes. John was previously CEO of Nemus Bioscience and served as a strategic consultant working with early stage healthcare companies. He served as SVP of Marketing for Tethys Bioscience, a diabetes diagnostic company and CEO of EEG Spectrum International, a private device company. He served in a series of Commercial positions, including the Global Commercial Leader in Oncology at Amgen where he led multiple teams in developing oncology assets from preclinical to phase IV. Prior to Amgen, Mr. Hollister started his pharmaceutical career at SmithKline Beecham. Mr. Hollister has his BA in Economics from Stanford University and his MBA from the Drucker Center at the Claremont Graduate University.less